share_log

荃信生物-B:自願公告QX005N注射液治療結節性癢疹(PN)的II期臨床試驗數據於中華醫學會第二十九次皮膚性病學術年會發佈

QYUNS-B: VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL DATA OF QX005N INJECTION FOR TREATMENT OF PRURIGO NODULARIS (PN) RELEASED AT THE 29TH ANNUAL MEETING OF CHINESE SOCIETY OF DERMATOLOGY

HKEX ·  Jun 14, 2024 06:30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more